Mexico Urology Devices Market Overview,2030

The urology devices market in Mexico has evolved rapidly in recent years, driven by the modernization of hospital infrastructure, rising awareness of urological health, and the steady integration of advanced diagnostic and surgical technologies. Major institutions such as the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City and Hospital Ángeles Lomas in Naucalpan have become key centers for adopting minimally invasive and robotic-assisted urology practices. The country’s demand for endoscopic and laser-based urological procedures has risen significantly due to the growing incidence of kidney stones, prostate enlargement, and bladder disorders linked to dietary changes and an aging population. Mexico’s health ministry, Secretaría de Salud, has emphasized preventive urology and improved access to chronic kidney care through public programs implemented by the Instituto Mexicano del Seguro Social (IMSS) and Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE). The introduction of flexible and digital endoscopes in tertiary care hospitals has replaced many conventional rigid systems, improving both accuracy and patient recovery outcomes. Smart catheters and sensor-enabled monitoring systems are being piloted in hospitals in Monterrey and Guadalajara for real-time urinary tracking, while tele-urology initiatives supported by the Universidad Nacional Autónoma de México have expanded specialist access in remote areas. The use of cloud-based patient data and AI-driven imaging systems for prostate cancer detection has also begun in collaboration with Siemens Healthineers and local research institutions. Home-based urology devices, particularly intermittent catheters and portable dialysis machines, have gained momentum under national programs addressing chronic kidney disease, which affects more than 10 percent of the population. With regulations overseen by the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), Mexico’s device manufacturers comply with FDA and ISO-equivalent standards, prioritizing safe sterilization, sustainable packaging, and waste management as hospitals transition toward greater use of disposable and eco-conscious urology instruments.

According to the research report, ""Mexico Urology Devices Market Overview, 2030,"" published by Bonafide Research, the Mexico Urology Devices market is anticipated to add to more than USD 330 Million by 2025–30. Mexico’s urology devices market has demonstrated strong progress through technological adoption, healthcare investment, and growing collaboration between global manufacturers and domestic healthcare providers. The shift toward outpatient and day-care urology has gained traction, with leading private networks such as Grupo Ángeles and Médica Sur offering same-day procedures for kidney stone removal and prostate treatments using compact laser systems from companies like Dornier MedTech and Olympus. Robotic and minimally invasive surgeries have expanded across major metropolitan hospitals, with Intuitive Surgical’s da Vinci system introduced at the Centro Médico ABC for complex prostatectomies and nephrectomies. Mexico’s competitive landscape includes key global players such as Boston Scientific, B. Braun, and Coloplast, which distribute through local partners like Intermed and Hospitaria. Laboratorios Pisa, based in Guadalajara, has diversified its medical technology division to manufacture and supply dialysis and endoscopy accessories, supporting the domestic production base. Public insurance systems under IMSS and ISSSTE reimburse for a wide range of urological procedures, while private insurers including GNP Seguros and AXA México offer full coverage for minimally invasive treatments. The Mexican government’s National Program for Kidney Health launched in coordination with the Pan American Health Organization has improved early screening for renal and prostate diseases, increasing the demand for diagnostic devices. Universities such as Tecnológico de Monterrey collaborate with Medtronic and Stryker on research into nano-coating technologies and biocompatible materials for reusable urological tools. Distribution channels remain centralized in Mexico City, with regional cold chain networks managed by distributors like Cardinal Health Mexico ensuring device integrity. Hospitals often lease or share advanced systems through medical equipment financing services offered by Banorte and BBVA, improving accessibility across regions.

In Mexico, the urology devices market by type encompasses a wide range of medical technologies that support diagnosis, treatment, and long-term management of urinary tract and male reproductive disorders. The product category includes endoscopes, cystoscopes, ureteroscopes, laser and lithotripsy systems, and dialysis devices used in leading hospitals such as Hospital General de México and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Flexible and rigid endoscopes from international manufacturers like Olympus and Karl Storz are utilized across urban urology centers in Mexico City, Guadalajara, and Monterrey for bladder and ureteral visualization. Laser and lithotripsy devices, including Holmium:YAG and pneumatic lithotripters, are commonly installed in tertiary facilities for minimally invasive stone removal, particularly in northern states where kidney stone prevalence is higher due to climate and water mineral content. Dialysis devices are an essential part of integrated urology and nephrology care in Mexico’s public hospitals, such as Instituto Mexicano del Seguro Social (IMSS) centers, where they are used to manage chronic renal failure linked to diabetes and hypertension. The accessories segment consists of Foley catheters, ureteral stents, intermittent catheters, and drainage bags, all of which are routinely used across both inpatient and outpatient environments. Mexican distributors source catheters and lubricants from brands like Coloplast, Teleflex, and Cook Medical, ensuring access to sterile, patient-friendly consumables. Lubricating gels are commonly used during diagnostic and surgical procedures to minimize discomfort and prevent tissue injury. With the growing emphasis on infection control, public hospitals and private clinics in Mexico have been adopting single-use catheters and disposable cystoscopes to reduce cross-contamination risks. The high-value capital equipment and everyday consumables defines the structure of the urology device market in Mexico, with hospitals relying heavily on global suppliers and local distributors to maintain consistent access to advanced, safe, and effective technologies.

In Mexico, urology devices are utilized across a diverse spectrum of clinical applications reflecting the country’s demographic and health challenges. Urolithiasis, or stone disease, is one of the most common urological conditions in Mexico due to high calcium content in water and dietary factors. Hospitals such as Hospital Ángeles Pedregal and Centro Médico Nacional Siglo XXI use ureteroscopes, laser lithotripters, and shock wave lithotripsy systems for treating kidney and ureteral stones. Benign Prostatic Hyperplasia (BPH) is frequently treated in urban and regional urology centers using laser resection systems and minimally invasive implants designed to alleviate urinary obstruction in older male populations. Urological cancers, particularly prostate and bladder cancers, are treated using endoscopic surgical systems, biopsy tools, and ablation devices at specialized cancer hospitals like Instituto Nacional de Cancerología in Mexico City. For urinary incontinence and pelvic organ prolapse, Mexican urogynecology departments employ slings, artificial sphincters, and bulking agents for women, especially in public hospitals where post-partum incontinence is common. Erectile dysfunction treatments in private clinics involve penile prostheses, vacuum erection devices, and pharmacologically assisted therapies for men who do not respond to medication. Kidney diseases, which are increasingly prevalent due to rising rates of diabetes and hypertension, are managed with dialysis machines and catheter-based drainage systems in collaboration between urologists and nephrologists. Other applications, such as pediatric urology, strictures, and urinary infections, involve smaller endoscopes and specialized catheter systems used in institutions like Hospital Infantil de México Federico Gómez. Mexican clinicians rely on imported technologies combined with locally available consumables, supported by ongoing training initiatives from international manufacturers, ensuring high standards of care across both public and private healthcare sectors.

In Mexico, the use of urology devices is concentrated across hospitals, clinics, and dialysis centers that form the backbone of the nation’s urological care infrastructure. Hospitals and clinics represent the dominant end-use environment, encompassing public facilities under the Secretaría de Salud and IMSS as well as private institutions like Hospital Zambrano Hellion and Médica Sur. These facilities employ a wide range of urology devices, including digital cystoscopes, flexible ureteroscopes, laser lithotripters, and endoscopic resection systems. In teaching hospitals such as Hospital General de México and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, advanced endoscopy units and minimally invasive surgical suites support training for urologists while delivering patient care. Clinics in metropolitan areas offer diagnostic procedures using portable cystoscopy systems and office-based lithotripsy devices, catering to the growing demand for outpatient treatments. Dialysis centers, both public and private, play a vital role in managing patients with chronic kidney disease and renal failure, which are prevalent in Mexico’s northern and central regions. Centers operated by Fresenius Medical Care, Baxter, and local providers in Monterrey and Guadalajara use hemodialysis machines, peritoneal dialysis systems, and vascular access kits to manage long-term renal dysfunction. Many dialysis facilities are integrated within hospital networks, enabling close collaboration between urologists and nephrologists to address urinary tract complications associated with renal conditions. Preventive programs in states like Jalisco and Puebla have improved access to dialysis care and encouraged earlier urological intervention. Across both hospitals and dialysis centers, infection control and cost efficiency are key priorities, prompting steady adoption of single-use catheters and disposable endoscopic accessories. Mexico’s healthcare institutions continue to balance modern technology adoption with accessibility and affordability, ensuring that both urban and regional facilities can meet the growing burden of urological and renal diseases. 

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Urology Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Product
• Accessories

By Application
• Urolithiasis (Stone Disease)
• Benign Prostatic Hyperplasia (BPH)
• Urological Cancers
• Urinary Incontinence & Pelvic Organ Prolapse
• Erectile Dysfunction
• Kidney Diseases
• Other Applications (Pediatrics, Strictures, Infections, etc.)

By End Use
• Hospitals and clinics
• Dialysis centers
• Others (Home care settings) Show more